Arvinas Appoints New Directors, Adjusts Executive Compensation
Ticker: ARVN · Form: 8-K · Filed: Jul 9, 2025 · CIK: 1655759
| Field | Detail |
|---|---|
| Company | Arvinas, Inc. (ARVN) |
| Form Type | 8-K |
| Filed Date | Jul 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
Related Tickers: ARVN
TL;DR
Arvinas adds two directors and updates CEO/CFO pay packages effective today.
AI Summary
Arvinas, Inc. announced on July 9, 2025, changes in its board of directors and executive compensation. Specifically, the company elected two new directors, Dr. Andrew G. von Eschenbach and Ms. Sarah E. Kelly, to its Board of Directors. Additionally, the company entered into new employment agreements with its Chief Executive Officer, Dr. John G. Martin, and Chief Financial Officer, Ms. Lisa A. Bright, effective July 9, 2025, detailing their compensation packages.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future performance, impacting investor confidence.
Risk Assessment
Risk Level: medium — Changes in board and executive compensation can sometimes precede significant strategic shifts or indicate internal dynamics that may affect future performance.
Key Players & Entities
- Arvinas, Inc. (company) — Registrant
- Dr. Andrew G. von Eschenbach (person) — Newly elected Director
- Ms. Sarah E. Kelly (person) — Newly elected Director
- Dr. John G. Martin (person) — Chief Executive Officer
- Ms. Lisa A. Bright (person) — Chief Financial Officer
- July 9, 2025 (date) — Effective date of changes
FAQ
Who were the new directors elected to Arvinas, Inc.'s Board of Directors?
Dr. Andrew G. von Eschenbach and Ms. Sarah E. Kelly were elected as new directors.
When were the changes in directorship and executive compensation effective?
The changes were effective as of July 9, 2025.
What specific roles did the newly appointed directors hold prior to their election?
The filing does not specify their prior roles, only that they were elected to the Board of Directors.
Were there any changes to the compensation of other named executive officers besides the CEO and CFO?
The filing specifically mentions new employment agreements for the Chief Executive Officer and Chief Financial Officer, but does not detail changes for other officers.
What is the principal executive office address for Arvinas, Inc.?
The principal executive offices are located at 5 Science Park, 395 Winchester Ave., New Haven, Connecticut 06511.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 9, 2025 by Dr. Andrew G. von Eschenbach regarding ARVINAS, INC. (ARVN).